NYSE:CAH - Cardinal Health Stock Price, Price Target & More

$63.57 +1.21 (+1.94 %)

(As of 04/26/2018 09:25 AM ET)

Previous Close$62.36

Today's Range$62.05 - $63.84

52-Week Range$54.66 - $80.37

Volume3.07 million shs

Average Volume2.98 million shs

Market Capitalization$19.63 billion

P/E Ratio11.77

Dividend Yield2.97%

Beta1.07

About Cardinal Health (NYSE:CAH)

Cardinal Health, Inc. operates as an integrated healthcare services and products company worldwide. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers. It offers distribution, inventory management, data reporting, new product launch support, and chargeback administration services to pharmaceutical manufacturers; pharmacy and medication therapy management, and patient outcomes services to hospitals, other healthcare providers, and payers; and consulting, patient support, and other services to pharmaceutical manufacturers and healthcare providers. This segment also operates nuclear pharmacies and manufacturing facilities that manufacture, prepare, and deliver radiopharmaceuticals, as well as operates direct-to-patient specialty pharmacies; offers logistics, marketing, and other services; and repackages generic pharmaceuticals and over-the-counter healthcare products. The company's Medical segment manufactures and sources medical, surgical, and laboratory products, including cardiovascular and endovascular products; wound care products; surgical drapes, gowns, and apparel; exam and surgical gloves; fluid suction and collection systems; and incontinence, enteral feeding, urology, operating room supply, electrode and needle, and syringe and sharps disposal product lines. It also distributes medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers, as well as to patients in the home; and assembles and sells sterile and non-sterile procedure kits. In addition, it offers supply chain services to healthcare providers; and post-acute care management, and transition services and software to hospitals, other healthcare providers, and payers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

Receive CAH News and Ratings via Email

Sign-up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries

Sub-IndustryHealth Care Distributors

SectorMedical

SymbolNYSE:CAH

CUSIP14149Y10

Webwww.cardinalhealth.com

Phone614-757-5000

Debt

Debt-to-Equity Ratio1.19%

Current Ratio1.09%

Quick Ratio0.57%

Price-To-Earnings

Trailing P/E Ratio11.77

Forward P/E Ratio11.75

P/E Growth1.43

Sales & Book Value

Annual Sales$129.98 billion

Price / Sales0.15

Cash Flow$7.8871 per share

Price / Cash8.06

Book Value$21.62 per share

Price / Book2.94

Profitability

EPS (Most Recent Fiscal Year)$5.40

Net Income$1.29 billion

Net Margins1.37%

Return on Equity24.81%

Return on Assets4.34%

Miscellaneous

Employees28,000

Outstanding Shares314,710,000

How to Become a New Pot Stock Millionaire

Cardinal Health (NYSE:CAH) Frequently Asked Questions

What is Cardinal Health's stock symbol?

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health announced a quarterly dividend on Wednesday, February 7th. Investors of record on Monday, April 2nd will be given a dividend of $0.4624 per share on Sunday, April 15th. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.91%. The ex-dividend date is Thursday, March 29th. View Cardinal Health's Dividend History.

How will Cardinal Health's stock buyback program work?

Cardinal Health declared that its Board of Directors has authorized a stock buyback plan on Thursday, February 8th 2018, which authorizes the company to repurchase $1,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company's leadership believes its stock is undervalued.

How were Cardinal Health's earnings last quarter?

Cardinal Health (NYSE:CAH) posted its quarterly earnings data on Thursday, February, 8th. The company reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.14 by $0.17. The company earned $35.19 billion during the quarter, compared to the consensus estimate of $34.63 billion. Cardinal Health had a return on equity of 24.81% and a net margin of 1.37%. The company's revenue for the quarter was up 6.1% on a year-over-year basis. During the same period in the prior year, the business earned $1.34 EPS. View Cardinal Health's Earnings History.

When is Cardinal Health's next earnings date?

Cardinal Health is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Cardinal Health.

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health updated its FY18 earnings guidance on Thursday, February, 8th. The company provided earnings per share (EPS) guidance of $5.25-$5.50 for the period, compared to the Thomson Reuters consensus estimate of $5.16.

What price target have analysts set for CAH?

16 equities research analysts have issued 12 month price objectives for Cardinal Health's shares. Their forecasts range from $64.00 to $85.00. On average, they expect Cardinal Health's share price to reach $74.2308 in the next twelve months. View Analyst Ratings for Cardinal Health.

Who are some of Cardinal Health's key competitors?

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbal Center (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), BiOasis Technologies (BIOAF) and Medizone International (MZEI).

Who are Cardinal Health's key executives?

Cardinal Health's management team includes the folowing people:

Mr. George S. Barrett, Exec. Chairman (Age 63)
Mr. Michael C. Kaufmann, CEO & Director (Age 55)
Mr. Craig S. Morford, Chief Legal & Compliance Officer (Age 59)
Mr. Jon L. Giacomin, Chief Exec. Officer of Medical Segment (Age 53)
Mr. Donald M. Casey Jr., Chief Exec. Officer of Medical Segment (Age 58)

Has Cardinal Health been receiving favorable news coverage?

News stories about CAH stock have trended positive recently, Accern Sentiment reports. Accern scores the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cardinal Health earned a news impact score of 0.27 on Accern's scale. They also assigned media coverage about the company an impact score of 46.74 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of Cardinal Health?

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cardinal Health's stock price today?

One share of CAH stock can currently be purchased for approximately $63.57.

How big of a company is Cardinal Health?

Cardinal Health has a market capitalization of $19.63 billion and generates $129.98 billion in revenue each year. The company earns $1.29 billion in net income (profit) each year or $5.40 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

How can I contact Cardinal Health?

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]

MarketBeat Community Rating for Cardinal Health (CAH)

Community Ranking:		3.0 out of 5 ( )
Outperform Votes:		526 (Vote Outperform)
Underperform Votes:		356 (Vote Underperform)
Total Votes:		882

MarketBeat's community ratings are surveys of what our community members think about Cardinal Health and other stocks. Vote "Outperform" if you believe CAH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CAH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Cardinal Health (NYSE:CAH) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

16 Wall Street analysts have issued ratings and price targets for Cardinal Health in the last 12 months. Their average twelve-month price target is $74.2308, suggesting that the stock has a possible upside of 16.77%. The high price target for CAH is $85.00 and the low price target for CAH is $64.00. There are currently 2 sell ratings, 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.13	2.00	2.13	2.31
Ratings Breakdown:	2 Sell Rating(s) 10 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 13 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 12 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 9 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$74.2308	$73.75	$73.4545	$75.50
Price Target Upside:	16.77% upside	5.30% upside	0.33% upside	13.64% upside

Cardinal Health (NYSE:CAH) Consensus Price Target History

Price Target History for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE:CAH) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/24/2018	Royal Bank of Canada	Set Price Target	Hold	$81.00	Medium
4/24/2018	Leerink Swann	Upgrade	Market Perform -> Outperform	$75.00	Low
4/16/2018	Barclays	Lower Price Target	Equal Weight -> Equal Weight	$74.00 -> $68.00	Medium
4/2/2018	Argus	Upgrade	Hold -> Buy	$85.00	High
2/27/2018	Bank of America	Initiated Coverage	Underperform -> Underperform	$69.00	Low
2/9/2018	Jefferies Group	Set Price Target	Hold	$72.00	Low
1/24/2018	Mizuho	Set Price Target	Hold	$73.00	Low
1/17/2018	Robert W. Baird	Reiterated Rating	Hold	$80.00	Medium
1/4/2018	Evercore ISI	Initiated Coverage	In -> In-Line	$67.00	Medium
12/4/2017	Deutsche Bank	Initiated Coverage	Hold	$64.00	High
11/20/2017	Morgan Stanley	Downgrade	Equal Weight -> Underweight		N/A
10/12/2017	Needham & Company LLC	Reiterated Rating	Hold		N/A
10/10/2017	Cowen	Upgrade	Buy	$74.00	N/A
8/9/2017	UBS	Reiterated Rating	Neutral	$79.00 -> $76.00	Medium
8/3/2017	Credit Suisse Group	Lower Price Target	Outperform	$87.00 -> $81.00	Medium
4/28/2017	Tigress Financial	Initiated Coverage	Neutral -> Neutral		Low
4/19/2017	William Blair	Downgrade	Outperform -> Market Perform		Low
10/10/2016	Cleveland Research	Downgrade	Buy -> Neutral		N/A
9/16/2016	Goldman Sachs	Downgrade	Buy -> Neutral	$90.00 -> $83.00	N/A
8/3/2016	Citigroup	Boost Price Target	Neutral	$87.00 -> $93.00	N/A
6/20/2016	FBR & Co	Reiterated Rating	Buy		N/A
6/1/2016	Raymond James	Downgrade	Outperform -> Market Perform		N/A

(Data available from 4/26/2016 forward)

Cardinal Health (NYSE:CAH) Earnings History and Estimates Chart

Earnings by Quarter for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE:CAH) Earnings Estimates

2018 EPS Consensus Estimate: $5.10
2019 EPS Consensus Estimate: $6.41

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$0.99	$1.18	$1.08
Q2 2018	3	$1.10	$1.21	$1.16
Q3 2018	3	$1.43	$1.78	$1.55
Q4 2018	3	$1.23	$1.48	$1.31
Q1 2019	2	$1.40	$1.40	$1.40
Q2 2019	2	$1.59	$1.69	$1.64
Q3 2019	2	$1.73	$1.78	$1.76
Q4 2019	2	$1.58	$1.64	$1.61

Cardinal Health (NYSE CAH) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/3/2018
2/8/2018	Q2 2018	$1.14	$1.31	$34.6276 billion	$35.1860 billion	View	N/A
11/6/2017	Q1 2018	$1.00	$1.09	$33.4831 billion	$32.6410 billion	View	N/A
8/2/2017	Q4 2017	$1.24	$1.31	$32.7337 billion	$32.9660 billion	View	Listen
5/1/2017	Q3 2017	$1.4580	$1.53	$32.3016 billion	$31.8210 billion	View	Listen
2/7/2017	Q217	$1.23	$1.34	$33.63 billion	$33.10 billion	View	Listen
10/31/2016	Q117	$1.21	$1.24	$31.12 billion	$32.00 billion	View	Listen
8/2/2016	Q416	$1.13	$1.14	$31.06 billion	$31.40 billion	View	N/A
4/28/2016	Q316	$1.33	$1.43	$30.54 billion	$30.70 billion	View	Listen
2/1/2016	Q216	$1.26	$1.30	$29.23 billion	$31.40 billion	View	N/A
11/2/2015	Q116	$1.10	$1.38	$27.19 billion	$28.10 billion	View	N/A
7/30/2015	Q415	$0.99	$1.00	$26.05 billion	$27.50 billion	View	Listen
4/30/2015	Q3	$1.16	$1.19	$24.3979 billion	$25.3750 billion	View	N/A
1/29/2015	Q215	$1.11	$1.20	$23.43 billion	$25.50 billion	View	N/A
10/30/2014	Q115	$0.96	$1.00	$22.43 billion	$24.07 billion	View	N/A
8/4/2014	Q414	$0.81	$0.83	$21.88 billion	$2.90 billion	View	N/A
5/1/2014	Q314	$1.01	$1.01	$21.72 million	$21.40 million	View	N/A
1/31/2014	Q214	$0.84	$0.79	$20.74 billion	$22.20 billion	View	N/A
10/31/2013	Q114	$0.86	$1.10	$22.73 billion	$24.50 billion	View	N/A
8/1/2013	Q4 2013	$0.77	$0.79	$24.56 billion	$25.40 billion	View	N/A
5/2/2013	Q3 2013	$0.95	$1.20	$24.72 billion	$24.60 billion	View	N/A
2/5/2013	Q2 2013	$0.86	$0.93	$24.61 million	$22.75 million	View	N/A
10/30/2012	Q113	$0.79	$0.81	$26.33 million	$25.90 million	View	N/A
8/2/2012		$0.73	$0.73			View	N/A
5/3/2012		$0.88	$0.94			View	N/A
2/2/2012		$0.77	$0.81			View	N/A
10/27/2011		$0.72	$0.73			View	N/A
8/4/2011		$0.58	$0.59			View	N/A
4/28/2011		$0.69	$0.75			View	N/A
2/3/2011		$0.61	$0.69			View	N/A
10/28/2010	Q1 2011	$0.53	$0.64			View	N/A
8/5/2010	Q4 2010	$0.49	$0.50			View	N/A
4/29/2010	Q3 2010	$0.57	$0.61			View	N/A
1/28/2010	Q2 2010	$0.46	$0.57			View	N/A
11/5/2009	Q1 2010	$0.43	$0.54			View	N/A
8/18/2009	Q4 2009	$0.86	$0.86			View	N/A
4/30/2009	Q3 2009	$0.95	$0.97			View	N/A
2/5/2009	Q2 2009	$0.89	$0.93			View	N/A
10/29/2008	Q1 2009	$0.70	$0.74			View	N/A
8/7/2008	Q4 2008	$0.95	$0.97			View	N/A
5/1/2008	Q3 2008	$1.00	$1.08			View	N/A
1/29/2008	Q2 2008	$0.88	$0.90			View	N/A

(Earnings results data provided by Zacks Investment Research)

Cardinal Health (NYSE:CAH) Dividend Information

Cardinal Health pays an annual dividend of $1.85 per share, with a dividend yield of 2.91%. CAH's most recent quarterly dividend payment was Sunday, April 15. The company has grown its dividend for the last 13 consecutive years and is increasing its dividend by an average of 12.20% each year. Cardinal Health pays out 34.26% of its earnings out as a dividend.

Most Recent Dividend:	4/15/2018
Annual Dividend:	$1.85
Dividend Yield:	2.91%
Dividend Growth:	12.20% (3 Year Average)
Payout Ratio:	34.26% (Trailing 12 Months of Earnings) 34.20% (Based on This Year's Estimates) 30.48% (Based on Next Year's Estimates)
Track Record:	13 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE:CAH) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/7/2018	quarterly	$0.4624	2.95%	3/29/2018	4/2/2018	4/15/2018
11/8/2017	quarterly	$0.4624	3.05%	12/29/2017	1/2/2018	1/15/2018
8/9/2017	quarterly	$0.4624	2.75%	9/29/2017	10/2/2017	10/15/2017
5/3/2017	quarterly	$0.4624	2.54%	6/29/2017	7/3/2017	7/15/2017
2/2/2017	quarterly	$0.4489	2.4%	3/30/2017	4/3/2017	4/15/2017
11/3/2016	quarterly	$0.4489	2.76%	12/29/2016	1/3/2017	1/15/2017
8/8/2016	quarterly	$0.4489	2.14%	9/29/2016	10/3/2016	10/15/2016
5/4/2016	quarterly	$0.4489	2.29%	6/29/2016	7/1/2016	7/15/2016
2/2/2016	quarterly	$0.3870	2%	3/30/2016	4/1/2016	4/15/2016
11/4/2015	quarterly	$0.3870	1.76%	12/30/2015	1/4/2016	1/15/2016
8/5/2015	quarterly	$0.3870	1.83%	9/29/2015	10/1/2015	10/15/2015
5/6/2015	quarterly	$0.3870	1.82%	6/29/2015	7/1/2015	7/15/2015
2/3/2015	quarterly	$0.3425	1.62%	3/30/2015	4/1/2015	4/15/2015
11/5/2014	quarterly	$0.3425	1.72%	12/30/2014	1/2/2015	1/15/2015
8/6/2014	quarterly	$0.3425	1.96%	9/29/2014	10/1/2014	10/15/2014
5/7/2014	quarterly	$0.3425	2.14%	6/27/2014	7/1/2014	7/15/2014
2/5/2014	quarterly	$0.3025	1.83%	3/28/2014	4/1/2014	4/15/2014
11/6/2013	quarterly	$0.3025	1.99%	12/30/2013	1/2/2014	1/15/2014
8/7/2013	quarterly	$0.3025	2.35%	9/27/2013	10/1/2013	10/15/2013
5/2/2013	quarterly	$0.3025	2.61%	6/27/2013	7/1/2013	7/15/2013
2/6/2013	quarterly	$0.2750	2.46%	3/27/2013	4/1/2013	4/15/2013

(Data available from 1/1/2013 forward)

Cardinal Health (NYSE CAH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.97%
Institutional Ownership Percentage: 89.98%

Insider Trading History for Cardinal Health (NYSE:CAH)

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE CAH) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/20/2018	Jon L Giacomin	CEO	Sell	7,995	$68.78	$549,896.10	63,043
2/14/2018	Patricia Morrison	Insider	Sell	28,532	$66.30	$1,891,671.60	36,157
1/22/2018	Michael C Kaufmann	CEO	Sell	18,586	$73.90	$1,373,505.40	211,849
5/12/2017	Jon L Giacomin	CEO of Cardinal Health's pharmaceutical segment	Sell	23,270	$72.87	$1,695,684.90	55,440
2/10/2017	George S Barrett	Chairman	Sell	217,994	$77.23	$16,835,676.62	682,225
11/10/2016	George S Barrett	Chairman	Sell	217,995	$71.29	$15,540,863.55	682,226
8/18/2016	Patricia Morrison	Insider	Sell	43,959	$82.50	$3,626,617.50	99,662
8/18/2016	Stuart G Laws	SVP	Sell	9,703	$82.45	$800,012.35	2,718
8/16/2016	Jon L Giacomin	CEO	Sell	47,251	$82.77	$3,910,965.27	44,598
8/11/2016	Craig S Morford	Insider	Sell	12,697	$83.13	$1,055,501.61	90,811
8/10/2016	Donald M Jr. Casey	CEO	Sell	59,180	$83.59	$4,946,856.20	164,803
8/10/2016	George S Barrett	Chairman	Sell	250,000	$83.63	$20,907,500.00	510,762
8/9/2016	George S Barrett	CEO	Sell	129,818	$83.76	$10,873,555.68	510,762
8/8/2016	George S Barrett	CEO	Sell	20,428	$83.75	$1,710,845.00	510,762
5/20/2016	Carole S Watkins	Insider	Sell	84,617	$77.33	$6,543,432.61	116,202
11/6/2015	Falk T. Stephen	EVP	Sell	30,085	$87.66	$2,637,251.10	33,633
8/20/2015	George S. Barrett	CEO	Sell	300,000	$83.08	$24,924,000.00	406,134
5/12/2015	Falk T Stephen	EVP	Sell	39,428	$86.12	$3,395,539.36
5/11/2015	George S Barrett	CEO	Sell	300,000	$86.44	$25,932,000.00
3/4/2015	Colleen F Arnold	Director	Sell	9,801	$87.65	$859,057.65
3/3/2015	Richard C Notebaert	Director	Sell	9,801	$88.20	$864,448.20
2/20/2015	Carole S Watkins	Insider	Sell	33,847	$87.00	$2,944,689.00
2/10/2015	Carole S Watkins	Insider	Sell	50,770	$85.00	$4,315,450.00
2/10/2015	George S Barrett	CEO	Sell	300,000	$84.87	$25,461,000.00
11/7/2014	Mark R Blake	EVP	Sell	24,668	$79.50	$1,961,106.00
9/5/2014	Carole S Watkins	Insider	Sell	40,794	$75.00	$3,059,550.00
9/4/2014	Michael C Kaufmann	CEO	Sell	50,216	$74.95	$3,763,689.20
8/27/2014	Jeffrey William Henderson	CFO	Sell	26,567	$72.63	$1,929,561.21
8/18/2014	Jeffrey William Henderson	CFO	Sell	78,637	$72.06	$5,666,582.22
8/18/2014	Mark R Blake	EVP	Sell	4,782	$72.15	$345,021.30
8/18/2014	Michael C Kaufmann	CEO	Sell	6,833	$72.06	$492,385.98
8/8/2014	Craig S Morford	Insider	Sell	43,359	$70.03	$3,036,430.77
8/8/2014	Jeffrey William Henderson	CFO	Sell	118,093	$69.72	$8,233,443.96
7/24/2014	Mark R Blake	EVP	Sell	23,114	$73.41	$1,696,798.74
7/24/2014	Stuart G Laws	CAO	Sell	21,266	$72.50	$1,541,785.00
7/14/2014	Jeffrey William Henderson	CFO	Sell	23,632	$70.65	$1,669,600.80
5/19/2014	Mark Blake	EVP	Sell	4,703	$66.50	$312,749.50	24,416
5/13/2014	Mark Blake	EVP	Sell	2,822	$66.50	$187,663.00	29,119
5/7/2014	Jeffrey William Henderson	CFO	Sell	27,031	$63.83	$1,725,388.73	107,096
2/11/2014	Mark Blake	EVP	Sell	2,330	$68.53	$159,674.90	31,941
2/11/2014	Michael Kaufmann	CEO	Sell	388,995	$67.46	$26,241,602.70	115,969
2/10/2014	George Barrett	CEO	Sell	200,000	$66.64	$13,328,000.00	334,102
2/5/2014	Gregory Kenny	Director	Sell	18,175	$65.39	$1,188,463.25	19,584
2/4/2014	Carole Watkins	Insider	Sell	46,666	$65.71	$3,066,422.86	53,544
2/4/2014	Falk Stephen	EVP	Sell	17,926	$65.56	$1,175,228.56	24,239
2/4/2014	Richard Notebaert	Director	Sell	10,727	$65.68	$704,549.36	33,750
11/11/2013	George Barrett	CEO	Sell	200,000	$62.71	$12,542,000.00	334,102
9/11/2013	Mark R Blake	EVP	Sell	14,584	$51.53	$751,513.52
8/19/2013	Mark Blake	EVP	Sell	4,925	$51.27	$252,504.75	30,641
8/16/2013	Falk Stephen	EVP	Sell	10,000	$51.50	$515,000.00	34,239
8/15/2013	Craig Morford	Insider	Sell	20,000	$51.33	$1,026,600.00	81,554
8/13/2013	George Barrett	CEO	Sell	75,000	$52.09	$3,906,750.00	325,787
8/13/2013	Jeffrey William Henderson	CFO	Sell	54,590	$51.99	$2,838,134.10	167,390
8/8/2013	Calvin Darden	Director	Sell	3,254	$51.48	$167,515.92	18,131
8/5/2013	Mark Blake	EVP	Sell	29,166	$51.53	$1,502,923.98	32,741
7/26/2013	Jeffrey William Henderson	CFO	Sell	76,781	$50.99	$3,915,063.19
7/18/2013	Jeffrey William Henderson	CFO	Sell	57,623	$49.99	$2,880,573.77
7/15/2013	Jeffrey William Henderson	CFO	Sell	14,660	$49.99	$732,853.40
7/11/2013	Jeffrey William Henderson	CFO	Sell	83,211	$48.99	$4,076,506.89
6/19/2013	John F Finn	Director	Sell	11,070	$48.51	$537,005.70
5/28/2013	Jean G Spaulding	Director	Sell	8,350	$47.35	$395,372.50
5/22/2013	Richard C Notebaert	Director	Sell	3,197	$48.10	$153,775.70
5/20/2013	Carole S Watkins	Insider	Sell	4,612	$48.00	$221,376.00
5/20/2013	Jean G Spaulding	Director	Sell	1,666	$47.90	$79,801.40
11/1/2012	Stuart G Laws	CAO	Sell	2,564	$41.22	$105,688.08
10/4/2012	Jeffrey William Henderson	CFO	Sell	46,226	$40.00	$1,849,040.00

(Data available from 1/1/2013 forward)

Cardinal Health (NYSE CAH) News Headlines

Source:

Date	Headline
	Cardinal Health (CAH) Upgraded at Zacks Investment Research www.americanbankingnews.com - April 25 at 11:42 AM
	Royal Bank of Canada Reiterates $81.00 Price Target for Cardinal Health (CAH) www.americanbankingnews.com - April 25 at 10:30 AM
	Leerink Swann Weighs in on Cardinal Health's Q1 2019 Earnings (CAH) www.americanbankingnews.com - April 25 at 9:45 AM
	Contrasting PetIQ (PETQ) and Cardinal Health (CAH) www.americanbankingnews.com - April 24 at 9:14 PM
	What's in Store for Cardinal Health (CAH) in Q3 Earnings? finance.yahoo.com - April 24 at 5:40 PM
	What's in Store for Cardinal Health (CAH) in Q3 Earnings? finance.yahoo.com - April 24 at 5:40 PM
	Cardinal Health (CAH) Upgraded to Outperform by Leerink Swann www.americanbankingnews.com - April 24 at 8:55 AM
	Cardinal Health (CAH) Set to Announce Quarterly Earnings on Monday www.americanbankingnews.com - April 23 at 5:02 AM
	Cardinal Health (CAH) Receives Consensus Rating of "Hold" from Analysts www.americanbankingnews.com - April 22 at 7:42 PM
	Cardinal Health's (CAH) "Outperform" Rating Reaffirmed at Evercore ISI www.americanbankingnews.com - April 19 at 11:20 PM
	McKesson - Deeply Undervalued seekingalpha.com - April 19 at 5:47 PM
	Cardinal Health (CAH) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - April 19 at 1:56 PM
	Cardinal Health (CAH) Downgraded by Zacks Investment Research to Hold www.americanbankingnews.com - April 17 at 12:47 PM
	Cardinal Health (CAH) Downgraded by BidaskClub to Hold www.americanbankingnews.com - April 16 at 8:40 PM
	Cardinal Health (CAH) Price Target Cut to $68.00 by Analysts at Barclays www.americanbankingnews.com - April 16 at 2:24 PM
	Cardinal Health (CAH) Upgraded by Zacks Investment Research to Buy www.americanbankingnews.com - April 16 at 12:05 PM
	$33.58 Billion in Sales Expected for Cardinal Health (CAH) This Quarter www.americanbankingnews.com - April 16 at 4:00 AM
	Zacks: Analysts Expect Cardinal Health (CAH) Will Announce Earnings of $1.51 Per Share www.americanbankingnews.com - April 14 at 9:17 AM
	Credit Suisse Group Lowers Cardinal Health (CAH) Price Target to $81.00 www.americanbankingnews.com - April 13 at 5:29 PM
	Top Picks For Healthcare Dividend Rockstars finance.yahoo.com - April 13 at 8:13 AM
	Cardinal Health (CAH) Earns Neutral Rating from UBS www.americanbankingnews.com - April 12 at 3:58 PM
	Cardinal Health (CAH) Upgraded to Buy by Cowen www.americanbankingnews.com - April 7 at 4:29 PM
	Comparing Herbal Center (HLF) & Cardinal Health (CAH) www.americanbankingnews.com - April 6 at 11:27 PM
	Cardinal Health Begins Donation of Over 80,000 Doses of Life-Saving Narcan® for Distribution to Law Enforcement and First Responders in Appalachia finance.yahoo.com - April 4 at 4:20 PM
	Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year ... www.prnewswire.com - April 4 at 8:13 AM
	Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2018 on May 3 finance.yahoo.com - April 3 at 5:40 PM
	Argus Cites Cardinal Health's Margin Improvements In Upgrade finance.yahoo.com - April 2 at 5:32 PM
	Argus Upgrades Cardinal Health (CAH) to Buy www.americanbankingnews.com - April 2 at 9:04 AM
	Cardinal Health (CAH) PT Lowered to $67.00 www.americanbankingnews.com - April 1 at 2:38 PM
	Zacks Investment Research Upgrades Cardinal Health (CAH) to "Hold" www.americanbankingnews.com - April 1 at 8:50 AM
	Cardinal Health (CAH) Stock Rating Lowered by ValuEngine www.americanbankingnews.com - March 31 at 3:20 PM
	MacroGenics (MGNX) & Cardinal Health (CAH) Head-To-Head Analysis www.americanbankingnews.com - March 30 at 9:20 PM
	Zacks: Analysts Expect Cardinal Health Inc (CAH) Will Post Quarterly Sales of $33.51 Billion www.americanbankingnews.com - March 30 at 3:04 AM
	Cardinal Health Inc (CAH) Given Consensus Recommendation of "Hold" by Brokerages www.americanbankingnews.com - March 28 at 7:32 PM
	Survey Finds 40 Percent of Health Care Providers Have Canceled Surgical Cases Due to Lack of Supplies finance.yahoo.com - March 28 at 5:24 PM
	Cardinal Health (CAH) Coverage Initiated at Bank of America www.americanbankingnews.com - March 24 at 9:28 PM
	Is Cardinal Health (CAH) a Great Stock for Value Investors Right Now? - Nasdaq www.nasdaq.com - March 23 at 8:13 AM
	Is Cardinal Health (CAH) a Great Stock for Value Investors Right Now? finance.yahoo.com - March 22 at 5:43 PM
	Tuesday Sector Laggards: Utilities, Healthcare - Nasdaq.com - Nasdaq www.nasdaq.com - March 21 at 8:39 AM
	Cardinal Health Highlights Commitment To Gender Equity As Part Of Women's History Month Celebrations finance.yahoo.com - March 20 at 5:23 PM
	Cardinal Health: Keen Valuation And Dividend Growth - Seeking Alpha seekingalpha.com - March 19 at 8:14 AM
	Cardinal Health (CAH) & Bio-Rad Laboratories (BIO) Critical Analysis www.americanbankingnews.com - March 18 at 11:28 PM
	Will These Management Changes Drive Dentsply Sirona toward a New Growth Trajectory? finance.yahoo.com - March 16 at 6:35 PM
	Cardinal Health (CAH) Lifted to "B-" at TheStreet www.americanbankingnews.com - March 15 at 1:00 PM
	Cardinal Health Recognizes Nearly a Decade of Helping Healthcare ... - PR Newswire (press release) www.prnewswire.com - March 14 at 8:22 AM
	Cardinal Health Recognizes Nearly a Decade of Helping Healthcare Organizations Improve Patient Safety finance.yahoo.com - March 13 at 7:24 PM
	Zacks: Brokerages Expect Cardinal Health Inc (CAH) Will Announce Quarterly Sales of $33.51 Billion www.americanbankingnews.com - March 13 at 8:54 AM
	Free Post Earnings Research Report: Cardinal’s Revenue Gained 6%; Adjusted EPS Jumped 13% finance.yahoo.com - March 12 at 6:45 PM
	Cardinal Health (CAH) Up 7.5% Since Earnings Report: Can It Continue? finance.yahoo.com - March 12 at 8:27 AM
	Cardinal Health Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Corporation - PR Newswire (press release) www.prnewswire.com - March 9 at 8:12 AM

Cardinal Health (NYSE:CAH) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Cardinal Health (NYSE:CAH) Income Statement, Balance Sheet and Cash Flow Statement

Cardinal Health (NYSE CAH) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff